Connect with us

Hi, what are you looking for?


Missouri Governor Signs Law that Prohibits Pharmacists from Questioning the Effectiveness of Ivermectin and Hydroxychloroquine

Missouri Governor Mike Parson (R) on Tuesday signed legislation that will prevent state licensing boards from disciplining physicians who prescribe the wonder drugs Ivermectin and hydroxychloroquine.

The new law also prohibits pharmacists from questioning the prescription and its effectiveness.

Missouri legislature passed HB 2149 in early May, which modifies provisions relating to professional licensing with a vote of 139-4.

According to this new law which goes into effect in August, “The act of lawfully dispensing, prescribing, administering, or otherwise distributing ivermectin tablets or hydroxychloroquine sulfate tablets for human use shall not be grounds for denial, suspension, revocation, or other disciplinary action by the board.”

Kansas City Star reported:

The measure, which passed in the General Assembly last month, was attached to a bill that exempts military employees and contractors participating in a federal training program from licensing requirements if they hold licensing in another state. Parson’s office announced his signing of the legislation along with six other bills Tuesday.

Sen. Rick Brattin, a Harrisonville Republican who is running running for Missouri’s 4th District in Congress, previously told The Star he added the language regarding ivermectin and hydroxychloroquine after he spoke with doctors who worried they would lose their medical licenses for prescribing the drugs.

Brattin, who said he previously bought ivermectin for COVID-19 but has never taken it, described the drug as “politicized.”

“Unfortunately, because of the politicization of those two drugs, (doctors are) being targeted,” he said. “I wanted to protect them from that.”

The post Missouri Governor Signs Law that Prohibits Pharmacists from Questioning the Effectiveness of Ivermectin and Hydroxychloroquine appeared first on The Gateway Pundit.

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 | All Rights Reserved